Acumen Pharmaceuticals Inc
ABOS
Get informed when a big investor buys or sells
+ FollowMarket Cap$210.9M
Close$
$0.37
87.9% downside
Current Fair Value
87.9% downsideOvervalued by 87.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $210.90 Million |
|---|---|
| Enterprise Value | $183.03 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2 |
| Beta | 0.33 |
| Outstanding Shares | 72,250,694 |
Return
| Return on Equity | -183.44% |
|---|---|
| Return on Assets | -90.55% |
| Return on Invested Capital | -149.45% |
Valuation & Multiples
| P/E Ratio | -1.78 |
|---|---|
| PEG | 8.86 |
| Price to Sales | -3.1 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -2033.67 |
| Enterprise Value to EBIT | -1.77 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.55 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0891▲ 108.91% |
|---|---|
| Total Calls | 79,700▲ 197.39% |
| Total Puts | 86,800▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 72.76%▲ 13.88% |
|---|---|
| Total Invested | $108.54M▲ 44.26% |
| Investors Holding | 89▲ 18.00% |
ESG Score
No data
About Acumen Pharmaceuticals Inc
2,021 employees